Patent · US Active

Exendin-4 derivatives as selective glucagon receptor agonists

US9932381B2 · kind B2 · utility

0Cited by

226References

21Claims

0Family size

Assignee

Sanofi · FR

Inventors

Torsten Haack · Frankfurt am Main, DE
Siegfried Stengelin · Frankfurt am Main, DE
Andreas Evers · Frankfurt am Main, DE
Michael Wagner · Frankfurt am Main, DE
Bernd Henkel · Frankfurt am Main, DE

Key dates

Filing date	Jun 12, 2015
Grant date	Apr 3, 2018
Priority date	—
Expiry date	Jun 12, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to glucagon receptor agonists and their medical use, for example in the treatment of severe hypoglycemia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.